Systemic progression following complete cutaneous remission under bexarotene treatment for tumor-stage mycosis fungoides

J Am Acad Dermatol. 2009 Aug;61(2):361-2. doi: 10.1016/j.jaad.2009.02.019.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Bexarotene
  • Biopsy, Needle
  • Combined Modality Therapy
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mycosis Fungoides / pathology
  • Mycosis Fungoides / therapy*
  • Neoplasm Invasiveness / pathology*
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Retreatment
  • Risk Assessment
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Tetrahydronaphthalenes / adverse effects
  • Tetrahydronaphthalenes / therapeutic use*
  • Treatment Outcome

Substances

  • Tetrahydronaphthalenes
  • Bexarotene